Home > Boards > US Listed > Biotechs > Applied DNA Sciences Inc. (APDN)

Applied DNA Partners with Molecular Isotope Technologies to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
RodeKroet Member Profile
Followed By 4
Posts 1,287
Boards Moderated 1
Alias Born 11/10/15
160x600 placeholder
Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM... Business Wire - 12/5/2019 5:00:00 AM
 Applied DNA Sciences Subsidiary LineaRx Signs Agreement with TYME Technologies for Functional Invasive Circulating Tumor Ce... Business Wire - 11/26/2019 12:30:00 PM
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards Business Wire - 11/25/2019 1:17:00 PM
Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform Business Wire - 11/25/2019 9:15:00 AM
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/15/2019 12:08:00 PM
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/13/2019 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 11/13/2019 9:13:26 AM
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries Business Wire - 11/12/2019 9:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:17:47 PM
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors  Business Wire - 11/8/2019 3:22:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 3:15:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/1/2019 5:22:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:07:01 PM
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split Business Wire - 10/31/2019 1:00:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/25/2019 4:28:35 PM
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials Business Wire - 10/22/2019 8:30:00 AM
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance Business Wire - 10/16/2019 5:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/8/2019 4:02:30 PM
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal Business Wire - 10/4/2019 5:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/3/2019 4:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:32:21 AM
Applied DNA Receives Extension from Nasdaq Business Wire - 10/3/2019 5:00:00 AM
LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Pros... Business Wire - 10/1/2019 8:30:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/26/2019 5:23:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 4:03:37 PM
RodeKroet   Wednesday, 10/16/19 07:18:47 AM
Re: None
Post # of 57017 
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance
CertainT Platform Complemented by Stable-Isotopic Indicators Offers Brand Owners Increased Supply Chain Transparency and Product and Process Authentication
STONY BROOK, N.Y. – October 16, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”, the “Company”), a leader in polymerase chain reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced today that it has entered into a partnership with Molecular Isotope Technologies, LLC (“MIT LLC”), a pioneer and leader in the application of natural-abundance stable-isotopic analysis provided under the trademarks Nature’s Fingerprint® and IsoPedigree™. MIT LLC’s technology utilizes stable isotopic "fingerprints" as a method for verification of product origin and supply chain processing to support product claims.

For 20 years MIT LLC has provided patented services to the bio/pharmaceutical industry which have been successfully employed in various legal matters, supporting pharmaceutical patent-infringement and fraud lawsuits. These authentication services are tailored to specific product and supply chain processes and will be offered by Applied DNA as an additional component of its CertainT® platform to tag, test and track raw materials and finished goods. MIT LLC will support and promote the CertainT platform as a service complementary to its own.

“Through the combined power of our cutting-edge technologies, Applied DNA offers brand owners “one-stop-shop” access to unique analytical tools to verify product and process authenticity for brand assurance and provenance with forensic certainty. This partnership with MIT LLC enhances Applied DNA’s CertainT feature-set by offering additional datapoints for deeper product and supply chain intelligence supported by world-class forensic laboratory services. The large-scale tagging and authentication of customer-specific DNA identity at most any supply chain node, combined with genotyping identification allies perfectly with stable-isotopic identification of origin and process. We expect our enhanced portfolio will serve to further our penetration of key markets such as textiles, adding another level of identity for organic cotton, among other natural materials,” stated Judy Murrah, chief information officer of Applied DNA.

Dr. John P. Jasper, chief scientific officer and founder of MIT LLC, said, “Our partnership with Applied DNA offers great specificity in forensic authentication to our joint customers, amplifying product and process claims throughout highly complex global supply chains. Nearly 40 years of work in this area of natural-abundance stable-isotope science and service across several industries has led to a deep knowledge and insight into the chemistry which has evolved into patented processes for protecting intellectual-property and product claims.”

Stable-isotopic “fingerprints” within materials provide innate chemical evidence of their chemical, geographic, and industrial provenance and major processing-dependent characteristics. They derive from the natural abundance of various stable isotopes including carbon, nitrogen, oxygen, sulfur and others that vary in their isotopic ratios and are present in soil, water and other organic materials and become integrated with the chemical composition of a product from raw materials through synthetic intermediates to finished products. Discrete process steps may alter isotopic fingerprints, permitting the identification of deviations in locale or materiel. MIT LLC’s existing and pending patents variously encompass the use of natural-abundance stable-isotopic analysis for establishing both product and process fingerprints.

About Molecular Isotopes Technologies, LLC
Founded in 1999, Molecular Isotope Technologies (MIT LLC) owns and uses the trademarks Nature’s Fingerprint® and IsoPedigree™. Via highly precise natural-abundance stable-isotopic analysis, MIT LLC significantly contributes to the definition of intellectual-property provenance and to the mitigation of intellectual-property infringement of various organic (e.g., bio/pharmaceutical, agricultural, and other) products and the synthetic pathways by which they were produced. After having established the isotopic provenance and process pathways of various bio/pharmaceutical materials, MIT LLC has provided the isotopic evidence that has protected more than $2 billion of bio/pharmaceutical products.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and isolation of circulating tumor cells and the development of pre-clinical nucleic acid-based therapeutic drug candidates.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward-Looking Statements
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to its ability to continue as a going concern, its history of net losses, limited financial resources, limited market acceptance, uncertainties relating to its ability to maintain its NASDAQ listing in light of delisting notices received and its recent hearing, our ability to penetrate key markets, and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 18, 2018, as amended, our subsequent quarterly reports on Form 10-Q filed on February 7, 2019, May 9, 2019 and August 13, 2019, and other reports we file with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.

Sanjay M. Hurry, LHA Investor Relations
212-838-3777, shurry@lhai.com
Judy Murrah, Chief Information Officer
631-240-8819, judy.murrah@adnas.com

Facebook ? Twitter ? LinkedIn ?

Applied DNA Sciences
50 Health Sciences Drive
Stony Brook, NY 11790
Unsubscribe info@vanpoppelconsultancy.nl
Update Profile | About Constant Contact
Sent by heather.berry@adnas.com
in collaboration with
Trusted Email from Constant Contact - Try it FREE today.
Try email marketing for free today!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist